Study Finds Cannabinoid-Based Supplement Reduces Pain and Improves Life for Dogs With Osteoarthritis

A new study has revealed the potential of a cannabinoid-based dietary supplement, Pain ReliefTM, to significantly alleviate chronic pain and improve the quality of life in dogs suffering from osteoarthritis.

Conducted by researchers from Columbia University, the University of Naples Federico II, and the University of Milano, the study was published in the peer-reviewed journal Animals.

For the study, 21 adult crossbreed dogs with severe osteoarthrosis participated. Researchers compared the effects of Pain Pain ReliefTM, a cannabis-based medicine produced by Giantec in Italy, to a placebo.
Continue reading

Dallas Police Now Prohibited from Arresting for Possession of Four Ounces or Less of Marijuana, Odor No Longer Probable Cause for Searches

Dallas Police Department officers are now under new guidelines regarding marijuana possession enforcement

In November, Dallas voters overwhelmingly approved Proposition R, which decriminalizes the possession of up to four ounces of marijuana. Now, Dallas officers are no longer allowed to make arrests or issue citations for marijuana possession up to four ounces, according to a police memo that was sent to The Marijuana Herald. The memo was issued by Interim Police Chief Michael Igo.

Additionally, the memo states that the odor of marijuana can no longer serve as probable cause for searches or seizures, except in cases involving violent felonies or high-priority narcotics investigations.
Continue reading

Despite Being One of the First States to Legalize Marijuana, Personal Cultivation Remains a Felony in Washington

Washington State made history in 2012 by becoming one of the first two states to legalize recreational marijuana. However, despite its pioneering role in marijuana reform, Washington continues to prohibit personal cultivation for recreational users.

Growing marijuana at home in the state is a Class C felony, carrying penalties of up to five years in prison and fines of up to $10,000. This restrictive stance stands in stark contrast to the majority of the 24 states that have legalized recreational marijuana. Of these states, only Illinois, Delaware, and New Jersey join Washington in prohibiting home cultivation for non-medical purposes. However, in Illinois and Delaware, the penalty for doing so is just a civil infraction. In New Jersey, personal cultivation laws are nearly as strict as Washington, punishable by 3 to 5 years in jail.

While medical marijuana patients in Washington are permitted to grow up to six plants with proper authorization, recreational users must rely exclusively on licensed marijuana retail outlets. Efforts to change this policy have been introduced in recent sessions of the Washington Legislature, but have failed to gain enough support to advance. Currently, there is no word on whether a new bill addressing home grows will be introduced this year.
Continue reading

Michigan Now Offers the Lowest Marijuana Prices Per Ounce

For years, Oregon has had the cheapest prices for legal marijuana, but Michigan now holds that title.

Data released today by the Cannabis Regulatory Agency (CRA) shows that the average cost per ounce of marijuana as of December 31 is $69.20. This is a nearly 30% decrease from just a year ago, when prices were around $98 per ounce.

By comparison, in Oregon, the average price per ounce is around $80 per ounce. In other states, the average cost is often much higher. For example, in Massachusetts, the cost is $130 per ounce, and in Illinois and Ohio it’s around $200.
Continue reading

New Missouri Bill Would Legalize Psilocybin Therapy for Veterans

State Representative Richard West (R) introduced House Bill 829 in the Missouri legislature today, proposing a pathway for veterans to legally access psilocybin therapy under tightly regulated conditions.

Dried psilocybin mushrooms. (Photo credit: Kevin J. Beaty/Denverite).

The bill, aimed at supporting alternative treatments for mental health challenges, has been referred for further consideration.

HB 829 establishes a framework allowing veterans aged 21 and older to acquire, possess, and use psilocybin if they suffer from posttraumatic stress disorder (PTSD), major depressive disorder, substance use disorders, or are receiving end-of-life care. To qualify, veterans must participate in a research study, obtain documentation from a physician, and work with a trained facilitator, such as a healthcare professional meeting specific qualifications. Additionally, psilocybin would need to be tested by a state-licensed laboratory, and use would be capped at 150 milligrams annually.
Continue reading

Mississippi Lawmaker Files Bill to Decriminalize First-Time Marijuana Possession

State Representative Omeria Scott (D) has introduced House Bill 30, a measure that would decriminalize first-time possession of small amounts of marijuana and synthetic cannabinoids in Mississippi.

Filed today and referred to the Judiciary Committee, the bill represents a significant shift in the state’s approach to minor drug offenses.

Current Mississippi law states “If thirty (30) grams or less of marijuana or ten (10) grams or less of synthetic cannabinoids are possessed, the offense is punishable by a fine of not less than One Hundred Dollars ($100.00) nor more than Two Hundred Fifty Dollars ($250.00).” This leaves open the possibility of a misdemeanor charge with up to 90 days in jail.
Continue reading

New York Releases Annual Marijuana Equity Report: Over $1 Billion in Sales, 54% of Licenses Issued to Social Equity Applicants

The New York State Office of Cannabis Management (OCM) has released its annual Chief Equity Officer’s Report, “showcasing the progress and achievements of its Social and Economic Equity (SEE) Team in building a cannabis industry that is not only thriving but also prioritizes equity, inclusion, and economic opportunity.”

safe banking act

According to a press release sent today, this report details the transformative work accomplished thus far and offers a look ahead at the ambitious goals for 2025.

Key updates include:

Continue reading

Court Reschedules Alabama Medical Marijuana Licensing Hearing as Legal Drama Continues

A court hearing regarding medical marijuana licensing in Alabama, originally set for January 13, has been rescheduled for February 11 at 10 a.m.

During the February 11 hearing, the Alabama Court of Civil Appeals will hear arguments over Montgomery Circuit Court Judge James Anderson’s temporary restraining order against the Alabama Medical Cannabis Commission (AMCC). No reason for the delay was provided by the court.

Alabama’s medical marijuana program was established by state lawmakers in 2021, allowing individuals with 15 qualifying medical conditions—including cancer, PTSD, chronic pain, and terminal illnesses—to become a legal medical marijuana patient, if they receive a recommendation from a physician. However, the law limits allowable forms to tablets, capsules, oils, creams, patches, and inhalable liquids. Smoking and edibles are prohibited, though gummies are permitted in peach flavor only.
Continue reading

Connecticut: December Breaks Monthly Recreational Marijuana Sales Record

There was more recreational marijuana sold legally in December than any month prior, according to data just released by the Connecticut officials.

In December, licensed marijuana stores sold $18,417,317 worth of recreational marijuana products, in addition to $7,017,428 in medical marijuana products, combining for a total of $25,434,745. This brings the total for 2024 to $300 million.

Prior to December, the top month for recreational marijuana sales was August, with $17.9 million
Continue reading

Tilray Brands Reports Q2 2025 Financial Results, With 29% Year-Over-Year Gross Profit Increase

Tilray Brands, Inc., a global lifestyle and consumer packaged goods company that’s “leading the forefront of beverage, cannabis and wellness industries”, today reported financial results for its second quarter ended November 30, 2024.

Tilray has reported significant financial growth in the second quarter, with gross profit rising 29% year-over-year to $61 million and net revenue reaching a record $211 million, marking 9% growth overall and 10% in constant currency. The company saw a 36% increase in beverage revenue, a 25% boost in international cannabis sales, and a 13% gain in its wellness segment. Additionally, Tilray announced “Project 420,” a $25 million synergy plan aimed at enhancing its beverage business.

Irwin D. Simon, Chairman and Chief Executive Officer of Tilray Brands, stated, “In our fiscal second quarter, Tilray achieved strong results while making significant progress on our strategic plan. Our dedication to operational excellence has improved Gross Margins, Gross Profit, and overall profitability across our business segments, positioning us favorably for future success.”
Continue reading